The injectable GHK-Cu works at a different tissue level than the topical application that follows
Unknown Risks with Prolonged Use: As with any treatment, the long-term effects beyond a decade of continuous use are not fully studied, emphasizing the need for periodic medical evaluations
Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, et al
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
Medium chain triglyceride formulation comprising D-methionine as the therapeutic agent are prepared as described in Examples A5 and A6 with the exception that the JNK inhibitor is replaced with D-methionine